Opendata, web and dolomites

Olfactomics Surgery SIGNED


Total Cost €


EC-Contrib. €






 Olfactomics Surgery project word cloud

Explore the words cloud of the Olfactomics Surgery project. It provides you a very rough idea of what is the project "Olfactomics Surgery" about.

trend    financials    benefits    care    revenue    300    device    first    quality    consists    removed    healthcare    optimal    innovative    olfactomics    compromising    invasive    saved    impacts    specialists    applicable    2015    industry    smoke    patient    time    analyze    13    removal    hospital    surgeon    launched    society    commercial    preoperative    global    excellent    sensor    operation    reachable    reoperation    specialties    sold    200    impaired    company    direct    examination    clinical    savings    commercialize    sparing    life    workplaces    ranges    operated    minimally    software    imaging    surgeries    easily    team    additional    currently    60    surgical    data    university    medical    2019    900m    effectiveness    noninvasive    law    tissue    breakthrough    prostate    surgery    trl    tumor    000m    instrumentation    cancer    intestinal    finnish    international    pathological    performed    health    incomplete    founded    postoperative    oy    workflow    850m    women    follow    skin    2027    market    solution    rate    spinoff    100m    breast    connections   

Project "Olfactomics Surgery" data sheet

The following table provides information about the project.


Organization address
address: AAKKULANKATU 4 C 9
postcode: 33700
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Finland [FI]
 Total cost 2˙649˙375 €
 EC max contribution 1˙854˙562 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-04-01   to  2021-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OLFACTOMICS OY FI (TAMPERE) coordinator 1˙854˙562.00


 Project objective

Currently, cancer tumor removal operation is based on preoperative imaging and postoperative pathological examination. There is a strong global trend towards more tissue-sparing and minimally invasive surgery. If all cancer is not removed in the operation, a reoperation is needed, leading to additional costs, impaired cost-effectiveness and impaired quality of life of the patient. The rate of incomplete removal of a tumor ranges from 10-60%. The breakthrough innovative Olfactomics device allows the surgeon to analyze the operated tissue in real-time during cancer surgery leading to optimal tissue removal without compromising the workflow of the operation and facilitating the use of existing instrumentation. The solution is based on noninvasive, real-time analysis of surgical smoke. The reduced reoperation rate results in significant benefits for the patient, surgeon, hospital and society. The market potential is high. Easily reachable market for the breast cancer surgery is 850M€ and market for other applicable specialties (such as prostate cancer, skin cancer, and intestinal surgery) is over 2,000M€. Olfactomics Oy is a Finnish university-based spinoff company founded in 2015 to commercialize the results of over 10 years of clinical and technical research. The team consists of 13 specialists in surgery, medical technology, software, data analysis, financials and law. The team has excellent connections in the international healthcare industry and sensor technology industry. The technology is currently at TRL 7. The first commercial product for research use will be launched in 2019. This project will focus on scale-up to Olfactomics medical device on breast cancer surgery. The impacts by 2027 include: 3,000 Olfactomics devices sold; 300,000 Olfactomics breast cancer surgeries performed, 70,000 women saved from reoperation, 900M€ costs savings in health care, 100M€ revenue and 200 direct workplaces generated. Scale-up to several surgical areas will follow.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OLFACTOMICS SURGERY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OLFACTOMICS SURGERY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Woodywood pickering (2019)

Bio-based (fully renewable) cost effective Polymer for new generation of ecological Coatings leveraging a disruptive innovation in the use of Pickering emulsion.

Read More  

NextGen-O2k (2019)

Next Generation Instrument for In-Depth Analysis of Mitochondrial Fitness

Read More  

CodeAll (2019)

The development of an innovative toolkit for learning programming with the use of the Internet of Things sensors and actuators

Read More